dc.contributor.author | Villar, IC | en_US |
dc.contributor.author | Bubb, KJ | en_US |
dc.contributor.author | Moyes, AJ | en_US |
dc.contributor.author | Steiness, E | en_US |
dc.contributor.author | Gulbrandsen, T | en_US |
dc.contributor.author | Levy, FO | en_US |
dc.contributor.author | Hobbs, AJ | en_US |
dc.date.accessioned | 2016-10-18T11:28:37Z | |
dc.date.available | 2016-09-15 | en_US |
dc.date.issued | 2016-12 | en_US |
dc.date.submitted | 2016-10-04T16:08:48.410Z | |
dc.identifier.issn | 0007-1188 | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/15911 | |
dc.description.sponsorship | This work was supported by an Innovations Project Grant from The Norwegian Research Council in conjunction with Serodus ASA. | en_US |
dc.format.extent | 3386 - 3401 | en_US |
dc.relation.ispartof | BRITISH JOURNAL OF PHARMACOLOGY | en_US |
dc.rights | This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1111/bph.13634 | |
dc.title | Functional pharmacological characterization of SER100 in cardiovascular health and disease | en_US |
dc.type | Article | |
dc.rights.holder | This article is protected by copyright. All rights reserved. | |
dc.identifier.doi | 10.1111/bph.13634 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000387348900008&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 23 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 173 | en_US |